Literature DB >> 28522713

Amylases and Their Importance during Glycan Degradation: Genome Sequence Release of Salmonella Amylase Knockout Strains.

Narine Arabyan1,2, Bihua C Huang1,2, Bart C Weimer3,2.   

Abstract

Amylases catalyze the cleavage of α-d-1,4 and α-d-1,6-glycosidic bonds in starch and related carbohydrates. Amylases are widely distributed in nature and are important in carbohydrate metabolism. This is the release of four single and two double deletions in Salmonella enterica serovar Typhimurium LT2 that are important for glycan degradation during infection.
Copyright © 2017 Arabyan et al.

Entities:  

Year:  2017        PMID: 28522713      PMCID: PMC5477324          DOI: 10.1128/genomeA.00355-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Amylases in Salmonella spp. are poorly characterized glycosyl hydrolases. The importance of amylases during Salmonella infection is understudied, especially as new virulence factors. The genome of Salmonella enterica serovar Typhimurium LT2 contains four amylases that are classified under the glycoside hydrolase 13 (GH13) family: malS (periplasmic α-amylase), amyA (cytoplasmic α-amylase), glgX (glycogen-debranching enzyme), and glgB (1,4-α-glucan-branching enzyme). Although glgX and glgB are not annotated as amylases, both have a conserved α-amylase domain and function as amylases. Investigating the genomic diversity of microbial amylases will aid in understanding their importance during pathogenesis. Inhibitors of amylases can be new drug targets. Amylases play an important role by altering the host glycan profiles during infection to gain access of the host epithelial cells by binding to terminal mannose molecules to initiate glycan degradation, as was shown by Arabyan et al. (1). That group also demonstrated that each of the four mutant amylase strains (ΔmalS, ΔamyA, ΔglgX, and ΔglgB mutants) had different invasion phenotypes during the in vitro infection of differentiated colonic epithelial cells (Caco-2) (1); however, only the ΔmalS mutant significantly (P < 0.05) reduced adhesion and invasion during infection that were comparable to those seen with a nonpathogenic Salmonella strain (1). The 100K Pathogen Genome Project (http://www.100kgenomes.org) is a large-scale sequencing consortium that offers the use of new next-generation sequencing methods to provide cutting-edge methods for pathogen detection and control in the food supply. This project is focused on producing genomes of pathogenic isolates from the environment, plants, animals, and humans worldwide, providing new insights into the genetic diversity of Salmonella and other foodborne pathogens. These amylase mutant strains (four single-deletion and two double-deletion mutants) were constructed in the Weimer laboratory (UC Davis, Davis, CA) (1), as described by Datsenko and Wanner (2). Cultures were grown on 1.5% Luria-Bertani (LB) agar (Difco, Franklin Lakes, NJ) with 10 µg/ml chloramphenicol at 37°C and lysed (3); genomic DNA (gDNA) was extracted (4), checked for quality (5), and fragmented (6). Libraries were 350 to 500 bp (7, 8) and were indexed (96 genomes/lane) and sequenced (Illumina HiSeq 3000; PE150) (9–11) at UC Davis DNA Technologies Core (Davis, CA). Paired-end reads were de novo assembled using CLC Workbench version 6 (Qiagen), with default parameters. Here, the 100K Pathogen Genome Project has assembled four genomes of single- and two double-amylase-deletion strains of Salmonella enterica serovar Typhimurium LT2.

Accession number(s).

All sequences are publicly available and can be found at the 100K Project BioProject (NCBI PRJNA186441) in the Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra) and genome assemblies can be found in NCBI GenBank (Table 1).
TABLE 1 

Salmonella enterica serovar Typhimurium LT2 amylase deletion mutants

GenBank accession no.SRA accession no.Isolate nameMutationNo. of contigsCoverage (×)Total genome size (bp)No. of CDSsa
MXAY00000000SRR3622951BCW_7501ΔmalS651054,892,7834,797
MZNJ00000000SRR5288769BCW_7502ΔglgB642874,896,2774,809
MXAZ00000000SRR3622952BCW_7503ΔglgX501304,893,2614,799
MZNK00000000SRR5288768BCW_7513ΔinvA::ΔmalS611504,893,6964,809
MZNL00000000SRR5288767BCW_7521ΔflgJ::ΔmalS571394,896,7784,803
MZNM00000000SRR5288770BCW_8419ΔamyA581504,892,0554,802

CDSs, coding sequences.

Salmonella enterica serovar Typhimurium LT2 amylase deletion mutants CDSs, coding sequences.
  5 in total

1.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Complete Genome Sequences of a Clinical Isolate and an Environmental Isolate of Vibrio parahaemolyticus.

Authors:  Catharina H M Lüdeke; Nguyet Kong; Bart C Weimer; Markus Fischer; Jessica L Jones
Journal:  Genome Announc       Date:  2015-03-26

3.  Draft Genome Sequences of Campylobacter jejuni Strains That Cause Abortion in Livestock.

Authors:  Allison M Weis; Kristin A Clothier; Bihua C Huang; Nguyet Kong; Bart C Weimer
Journal:  Genome Announc       Date:  2016-12-01

4.  Large-Scale Release of Campylobacter Draft Genomes: Resources for Food Safety and Public Health from the 100K Pathogen Genome Project.

Authors:  Allison M Weis; Bihua C Huang; Dylan B Storey; Nguyet Kong; Poyin Chen; Narine Arabyan; Brent Gilpin; Carl Mason; Andrea K Townsend; Woutrina A Smith; Barbara A Byrne; Conor C Taff; Bart C Weimer
Journal:  Genome Announc       Date:  2017-01-05

5.  Salmonella Degrades the Host Glycocalyx Leading to Altered Infection and Glycan Remodeling.

Authors:  Narine Arabyan; Dayoung Park; Soraya Foutouhi; Allison M Weis; Bihua C Huang; Cynthia C Williams; Prerak Desai; Jigna Shah; Richard Jeannotte; Nguyet Kong; Carlito B Lebrilla; Bart C Weimer
Journal:  Sci Rep       Date:  2016-07-08       Impact factor: 4.379

  5 in total
  1 in total

1.  Whole Cell Cross-Linking to Discover Host-Microbe Protein Cognate Receptor/Ligand Pairs.

Authors:  Bart C Weimer; Poyin Chen; Prerak T Desai; Dong Chen; Jigna Shah
Journal:  Front Microbiol       Date:  2018-07-19       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.